Post Archives

Visitor Survey

Visitor Survey

thyroid

Link: Ethical Issues in the Management of Thyroid Disease

KEY POINTS  The focus of this article is on clinical ethics issues in the thyroid disease context.  In the context of thyroid disease management, clinical ethics dilemmas affect a wide range of health care providers: endocrinologists, primary care physicians, surgeons, oncologists, nuclear medicine specialists and technologists, genetic counselors, nurses, and physician assistants.  In autoimmune thyroid disease, there are unique challenges to informed consent, and potential duties to warn in severe hypothyroidism.  In thyroid cancer, the most common ethical issues revolve around truth-telling and advance care planning, and genetic screening for medullary thyroid cancer.  Novel ethical issues in thyroid disease include end of life discussions in poorly differentiated thyroid cancers; priority-set

 

The full study is not available but the first page is available at http://www.sciencedirect.com/science/article/pii/S0889852914000140?np=y.

This website is not a substitute for independent professional advice. Nothing contained in this site is intended to be used as medical advice. No articles, personal accounts, or other content are intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professionals advice.

Link: Thyroid Functions and Bipolar Affective Disorder

Accumulating evidence suggests that hypothalamo-pituitary-thyroid (HPT) axis dysfunction is relevant to the pathophysiology and clinical course of bipolar affective disorder. Hypothyroidism, either overt or more commonly subclinical, appears to the commonest abnormality found in bipolar disorder. The prevalence of thyroid dysfunction is also likely to be greater among patients with rapid cycling and other refractory forms of the disorder. Lithium-treatment has potent antithyroid effects and can induce hypothyroidism or exacerbate a preexisting hypothyroid state. Even minor perturbations of the HPT axis may affect the outcome of bipolar disorder, necessitating careful monitoring of thyroid functions of patients on treatment. Supplementation with high dose thyroxine can be considered in some patients with treatment-refractory bipolar disorder. Neurotransmitter, neuroimaging, and genetic studies have begun to provide clues, which could lead to an improved understanding of the thyroid-bipolar disorder connection, and more optimal ways of managing this potentially disabling condition.

The full text can be found at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144691/.

Copyright © 2011 Subho Chakrabarti.

This website is not a substitute for independent professional advice. Nothing contained in this site is intended to be used as medical advice. No articles, personal accounts, or other content are intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professionals advice.

Link: When Hashimoto’s is misdiagnosed as bipolar disorder

After a bipolar diagnosis, this patient was prescribed eight different psychotropic medications and received a dozen electroconvulsive treatments.

After six months of support for Hashimoto’s, her symptoms resolved and she is now drug-free, with the exception of thyroid hormone medication. Was her bipolar disorder simply misdiagnosed Hashimoto’s?

 

The full article can be found at http://drknews.com/when-hashimotos-is-misdiagnosed-as-bipolar-disorder/.

This website is not a substitute for independent professional advice. Nothing contained in this site is intended to be used as medical advice. No articles, personal accounts, or other content are intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professionals advice.

Link: Hashimoto’s Encephalitis by by Dr. Sarosh Irani, John Radcliffe Hospital, Oxford

 Hashimoto’s Encephalopathy (HE) was first described in 1966. It is a rare condition, which is probably of autoimmune origin. Autoimmunity describes disorders in which the immune system mistakenly attacks and destroys the body’s tissues. HE is usually defined by the presence of high levels of thyroid antibodies in the blood.  HE has been reported in all age groups but typically affects females of around 50 years of age. – The Encephalitis Society

To read the full text, proceed to http://www.encephalitis.info/information/types-of-encephalitis/types-of-autoimmune-encephalitis/hashimoto-s-encephalitis/

The full text of this article is found at Encephalitis Society. Copyright  © March 17th 2014 Dr. Sarosh Irani, John Radcliffe Hospital, Oxford

This link was posted by G.D. on 18th November to this thread – https://www.facebook.com/groups/564512313648230/permalink/588191237947004/.

This website is not a substitute for independent professional advice. Nothing contained in this site is intended to be used as medical advice. No articles, personal accounts, or other content are intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professionals advice.

Link: Encefalopatía de Hashimoto

The article discusses two forms of presentation, “vasculitic” which is remitting/relapsing and “progressive” which is characterized by confussion, psychosis, and potentially coma. The original article, published in Spanish, is located at http://www.imedicinas.com/pfw_files/cma/ArticulosR/Neurologia/2002/10/109100206280632.pdf.

The full text can be translated at https://translate.google.com/.

The full text of this article is found at imedicinas.com and was published in 2002.

Do you have the copyright information? Is there a tag missing?

This website is not a substitute for independent professional advice. Nothing contained in this site is intended to be used as medical advice. No articles, personal accounts, or other content are intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professionals advice.

Link: Hashimoto’s Thyroiditis in Patients With Normal Thyroid-stimulating Hormone Levels

This study discusses the impact that Hashimoto’s Thyroiditis (also known as Hashimoto’s Disease) on patient quality of life. It also touches on the topic of eurthyroid patients continuing to experience a range of symptoms even while remaining within reference ranges on Thyroid Function Tests. The study can be found at
http://www.medscape.com/viewarticle/760417

The full text of this article is found at Medscape. Copyright © 1994-2014 by WebMD LLC.

 

Is there a tag missing? Suggest a tag in the comments below.

This website is not a substitute for independent professional advice. Nothing contained in this site is intended to be used as medical advice. No articles, personal accounts, or other content are intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professionals advice.

Link: Hashimoto’s Encephalopathy: A Neuroendocrine Disorder

This link leads to an article about Hashimoto’s Encephalopathy by Beverly Seminara, a patient advocate for H.E. Copyright © Beverly Seminara 13 June 2005

Beverly Seminara is a patient advocate who herself has Hashimoto’s Encephalopathy. Recognizing that there is not much information disseminated about this rare condition, Beverly has researched and developed information and resources for H.E. patients. Please see Beverly’s informational website, Hashimoto’s Encephalopathy – A Complete List of Published Case Studies, and other information and articles online.

 

The website itself is run by Mary Shomon and provides information about thyroid disorders.

 

 

This website is not a substitute for independent professional advice. Nothing contained in this site is intended to be used as medical advice. No articles, personal accounts, or other content are intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professionals advice.

Link: Hashimoto’s Encephalopathy Presenting with Progressive Cerebellar Ataxia

This study discusses a 41 year old female with multiple neurological complaints. It further suggests that Hashimoto’s Encephalopathy should be included in the differential diagnosis of a treatable ataxia. To read the full text, proceed to http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077662/.

The full text of this article is found at PMC and was published in 2007.

Copyright © 2007 BMJ Publishing Group Ltd

 

 

 

 

 

 

This website is not a substitute for independent professional advice. Nothing contained in this site is intended to be used as medical advice. No articles, personal accounts, or other content are intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professionals advice.